You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) on Monday announced positive results from its global phase I BEHOLD-1 trial evaluating mocertatug rezetecan (Mo-Rez), a B7-H4-targeted antibody-drug conjugate, in gynaecological...
13 April 2026 - Life sciences company EKF Diagnostics Holdings plc (AIM: EKF) has acquired technology assets from Sweden-based Beep Insights AB, including its iOS and Android application designed for real-time glucose and lactate tracking in sports p...
13 April 2026 - Healthcare company Trellus Health plc (AIM: TRLS) announced on Monday that it has renewed its licensing agreement with biopharmaceutical company Pfizer Inc, extending the use of its patient support educational content within Pfizer�...
13 April 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday that the US Food and Drug Administration (FDA) has g...
13 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced on Monday that they have received European Commission approval for Dupixent (du...
13 April 2026 - Canadian pharmaceutical company Apotex Inc announced on Friday that its US subsidiary Apotex Corp has received the first US Food and Drug Administration (FDA) tentative approval for its Abbreviated New Drug Application (ANDA) for Sema...